Artal Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,005,500
| Closed | -$9.66M | – | 124 |
|
|
2023
Q4 | $9.66M | Sell |
1,005,500
-719,500
| -42% | -$6.91M | 0.32% | 34 |
|
|
2023
Q3 | $4.49M | Hold |
1,725,000
| – | – | 0.19% | 57 |
|
|
2023
Q2 | $8.06M | Sell |
1,725,000
-250,000
| -13% | -$1.17M | 0.25% | 55 |
|
|
2023
Q1 | $7.45M | Buy |
1,975,000
+1,225,000
| +163% | +$4.62M | 0.44% | 51 |
|
|
2022
Q4 | $2.36M | Hold |
750,000
| – | – | 0.13% | 79 |
|
|
2022
Q3 | $2.26M | Hold |
750,000
| – | – | 0.1% | 85 |
|
|
2022
Q2 | $1.87M | Hold |
750,000
| – | – | 0.1% | 98 |
|
|
2022
Q1 | $5.83M | Hold |
750,000
| – | – | 0.24% | 70 |
|
|
2021
Q4 | $3.13M | Hold |
750,000
| – | – | 0.08% | 116 |
|
|
2021
Q3 | $5.94M | Hold |
750,000
| – | – | 0.13% | 103 |
|
|
2021
Q2 | $6.06M | Buy |
750,000
+210,736
| +39% | +$1.7M | 0.12% | 107 |
|
|
2021
Q1 | $5.78M | Buy |
+539,264
| New | +$5.78M | 0.1% | 107 |
|